Author Archives: Mark Peplow

Chemical & Engineering News: Stale beer? There’s an app for that

Brewers could use a smartphone to read a simple colorimetric test for beer freshness.

Posted in Highlights | Comments Off on Chemical & Engineering News: Stale beer? There’s an app for that

Spectrum: My Subterranean Tour of London’s Crossrail

It’s a damp, freezing cold day in January, and I’m at the bottom of a massive hole in the ground …

Posted in Highlights | Comments Off on Spectrum: My Subterranean Tour of London’s Crossrail

Spectrum: The Digital Underground

London’s Crossrail Is a $21 Billion Test of Virtual Modeling.

Posted in Highlights | Comments Off on Spectrum: The Digital Underground

Crusading editor aims to shake things up in science

A profile of the BMJ’s editor, Fiona Godlee, for STAT magazine.

Posted in Profile | Comments Off on Crusading editor aims to shake things up in science

Malaria drug meets market resistance

Exclusive news article for Nature about artemisinin.

Posted in News reporting | Comments Off on Malaria drug meets market resistance

The hole story

Nature article about Swiss-cheese-like materials called metal–organic frameworks.

Posted in Feature reporting | Comments Off on The hole story

Nature: Liquid metal ‘balloons’ offer room-temperature soldering

Invention could help the microelectronics industry to connect circuit-board components without risking heat damage.

Posted in Highlights | Comments Off on Nature: Liquid metal ‘balloons’ offer room-temperature soldering

Chemical & Engineering News: Tiny enzyme tweak expands substrate palette

Changing just two amino acids transforms a picky aldolase into a cosmopolitan catalyst.

Posted in Highlights | Comments Off on Chemical & Engineering News: Tiny enzyme tweak expands substrate palette

Nature: Synthetic malaria drug meets market resistance

First commercial deployment of synthetic biology for medicine has modest impact.

Posted in Highlights | Comments Off on Nature: Synthetic malaria drug meets market resistance

ACS Central Science: A Conversation with Christina Smolke

The synthetic biology pioneer discusses how she reprogrammed yeast to produce opioids.

Posted in Highlights | Comments Off on ACS Central Science: A Conversation with Christina Smolke